share_log

HC Wainwright & Co. Reiterates Buy on Reviva Pharmaceuticals, Maintains $14 Price Target

HC Wainwright & Co. Reiterates Buy on Reviva Pharmaceuticals, Maintains $14 Price Target

HC Wainwright & Co.重申买入Reviva Pharmaceuticals,维持14美元的目标价。
Benzinga ·  06/20 06:15

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $14 price target.

HC Wainwright & Co. 分析师Raghuram Selvaraju 重申 Reviva Pharmaceuticals (纳斯达克:RVPH) 买入评级,维持目标价14美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发